✦ LIBER ✦

CDO1 Promoter Methylation is a Biomarker for Outcome Prediction of Anthracycline Treated, Estrogen Receptor-Positive, Lymph Node-Positive Breast Cancer Patients

✍ Scribed by Dimo Dietrich; Manuel Krispin; Jörn Dietrich; Anne Fassbender; Jörn Lewin; Nadia Harbeck; Manfred Schmitt; Serenella Eppenberger-Castori; Vincent Vuaroqueaux; Frédérique Spyratos; John A Foekens; Ralf Lesche; John WM Martens

Book ID: 115010042
Publisher: BioMed Central
Year: 2010
Tongue: English
Weight: 704 KB
Volume: 10
Category: Article
ISSN: 1471-2407
DOI: 10.1186/1471-2407-10-247

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High expression of gabarapl1 is associat

High expression of gabarapl1 is associated with a better outcome for patients with lymph node-positive breast cancer

✍ Berthier, A; Seguin, S; Sasco, A J; Bobin, J Y; De Laroche, G; Datchary, J; Saez 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 394 KB

Implementation of the American College o

Implementation of the American College of Surgeons Oncology Group Z1071 Trial Data in Clinical Practice: Is There a Way Forward for Sentinel Lymph Node Dissection in Clinically Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?

✍ Mittendorf, Elizabeth A.; Caudle, Abigail S.; Yang, Wei; Krishnamurthy, Savitri; 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 477 KB